Prostate-specific Membrane Antigen Imaging in Recurrent Medullary Thyroid Cancer: A New Theranostic Tracer in the Offing?

Prostate-specific membrane antigen (PSMA) expression has been shown in neovasculature of various malignancies. Recurrent medullary thyroid cancer (MTC) is difficult to treat. We present the findings on PSMA-positron emission tomography/computed tomography (PET/CT) of a 68-year-old man with MTC, who presented with a recurrent left paratracheal mass and rising calcitonin. The scan revealed significant uptake on PSMA imaging but not on 68Ga-DOTANOC PET/CT. 177Lu-PRRT is one of the therapeutic options in patients with recurrent MTC, but in this case was not possible due to lack of somatostatin receptor expression. Imaging evidence of PSMA expression alerts us to the potential use of 177Lu-DKFZ-PSMA-617 therapy in such patients.

[1]  A. Bychkov,et al.  PSMA expression by microvasculature of thyroid tumors – Potential implications for PSMA theranostics , 2017, Scientific Reports.

[2]  A. Sasikumar,et al.  68Ga-PSMA PET/CT Imaging in Multiple Myeloma. , 2017, Clinical nuclear medicine.

[3]  H. Everaert,et al.  Aspecific Uptake of 68GA-PSMA in Paget Disease of the Bone. , 2016, Clinical nuclear medicine.

[4]  A. Kneebone,et al.  Follicular Lymphoma Showing Avid Uptake on 68Ga PSMA-HBED-CC PET/CT. , 2016, Clinical nuclear medicine.

[5]  C. Bal,et al.  PSMA Expression in Papillary Thyroid Carcinoma: Opening a New Horizon in Management of Thyroid Cancer? , 2016, Clinical nuclear medicine.

[6]  H. Loh,et al.  Elevated 68Ga Prostate-Specific Membrane Antigen Activity in Metastatic Non-Small Cell Lung Cancer. , 2016, Clinical nuclear medicine.

[7]  A. Mcewan,et al.  Medullary thyroid carcinoma (MTC) treated with 177Lu-DOTATATE PRRT: a report of two cases. , 2015, Clinical nuclear medicine.

[8]  F. Mottaghy,et al.  First evidence of PSMA expression in differentiated thyroid cancer using [68Ga]PSMA-HBED-CC PET/CT , 2015, European Journal of Nuclear Medicine and Molecular Imaging.

[9]  S. Landas,et al.  Expression of Prostate-Specific Membrane Antigen in Normal and Malignant Human Tissues , 2006, World Journal of Surgery.

[10]  S. A. Wolfe,et al.  Upregulation of prostate specific membrane antigen/folate hydrolase transcription by an enhancer. , 2002, Gene.

[11]  V. Reuter,et al.  Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature. , 1999, Cancer research.

[12]  A. Jena,et al.  68Ga-PSMA Uptake in Hepatocellular Carcinoma. , 2017, Clinical nuclear medicine.

[13]  T. Poeppel,et al.  Imaging of Prostate-Specific Membrane Antigen Expression in Metastatic Differentiated Thyroid Cancer Using 68Ga-HBED-CC-PSMA PET/CT , 2017, Clinical nuclear medicine.